Global NGS-based RNA-sequencing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global NGS-based RNA-sequencing Market Research Report 2024
Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.
According to Mr Accuracy reports’s new survey, global NGS-based RNA-sequencing market is projected to reach US$ 5746.2 million in 2034, increasing from US$ 1832.5 million in 2024, with the CAGR of 17.4% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NGS-based RNA-sequencing market research.
Key companies engaged in the NGS-based RNA-sequencing industry include Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific and Roche, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of NGS-based RNA-sequencing were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole NGS-based RNA-sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global NGS-based RNA-sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The NGS-based RNA-sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global NGS-based RNA-sequencing market is projected to reach US$ 5746.2 million in 2034, increasing from US$ 1832.5 million in 2024, with the CAGR of 17.4% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NGS-based RNA-sequencing market research.
Key companies engaged in the NGS-based RNA-sequencing industry include Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific and Roche, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of NGS-based RNA-sequencing were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole NGS-based RNA-sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global NGS-based RNA-sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Segment by Application
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The NGS-based RNA-sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source